Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia

Measurable residual disease is associated with inferior outcomes in patients with acute myeloid leukemia (AML). Measurable residual disease monitoring enhances risk stratification and may guide therapeutic intervention. The European LeukemiaNet working party recently came to a consensus recommendati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Wenbin, Goldberg, Aaron D., Famulare, Christopher A., Devlin, Sean M., Nguyen, Nghia T., Sim, Sinnifer, Kabel, Charlene C., Patel, Minal A., McGovern, Erin M., Patel, Akshar, Schulman, Jessica, Dunbar, Andrew J., Epstein-Peterson, Zachary D., Menghrajani, Kamal N., Getta, Bartlomiej M., Cai, Sheng F., Geyer, Mark B., Glass, Jacob L., Taylor, Justin, Viny, Aaron D., Levine, Ross L., Zhang, Yanming, Giralt, Sergio A., Klimek, Virginia, Tallman, Martin S., Roshal, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601104/
https://www.ncbi.nlm.nih.gov/pubmed/30523054
http://dx.doi.org/10.3324/haematol.2018.203018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601104/
https://www.ncbi.nlm.nih.gov/pubmed/30523054
http://dx.doi.org/10.3324/haematol.2018.203018

Ejemplares similares